A recent report extends previous studies suggesting that the acquisition of PIK3CA mutations may be an important molecular event in the etiology of esophageal cancer (EC) and the mutations are associated with their clinical outcome [13–16]. This evidence concerns the gene PIK3CA and esophageal cancer.